Related Experiment Video
Updated: Jun 27, 2025

Author Spotlight: Obtaining High-Quality CSF and Blood Samples for Epilepsy Biomarker Discovery
Published on: September 1, 2023
Patient-reported outcomes in epilepsy: a case study exploring their usage and impact.
Simona Lattanzi1, Angela La Neve2
1Neurological Clinic, Department of Experimental and Clinical Medicine, Marche Polytechnic University, Ancona - Italy.
Epilepsy specialists see Patient-Reported Outcome (PRO) measures as vital for improving patient care and treatment success. Barriers like time and resources exist, but PROs can optimize epilepsy management and healthcare utilization.
Area of Science:
- Neurology
- Clinical Research
- Health Services Research
Background:
- Epilepsy management relies on effective patient assessment.
- Patient-Reported Outcome (PRO) measures offer insights into patient experience and quality of life.
- Understanding specialist perspectives on PRO use is crucial for optimizing epilepsy care.
Purpose of the Study:
- To gather insights from epilepsy specialists regarding the utilization of Patient-Reported Outcome (PRO) measures.
- To explore the impact of PROs on the management of epilepsy and healthcare resource utilization.
Main Methods:
- A structured survey was administered to heads of two epilepsy referral units at a tertiary care hospital.
- Data collection involved paper-based questionnaires and face-to-face interviews.
- Various quality of life and symptom assessment scales were utilized, including QOLIE-31, GAD-7, and SF-36.
Main Results:
- Specialists reached a consensus on the favorable impact of PROs on patient and disease management, and treatment success measurement.
- PROs were considered as important as treatment efficacy and tolerability.
- Key barriers to PRO implementation included lack of time, personnel, and economic resources.
- PROs have the potential to reduce visits and treatments while increasing patient-centered care and specialized services.
Conclusions:
- A uniform perception exists regarding the role of PROs in optimizing epilepsy care, despite variations in current data collection practices.
- Standardized PRO use is considered beneficial, with increased human resources identified as a priority for successful implementation.
More Related Videos
Related Concept Videos
Arteries of the Lower Limbs
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Glutamate Antagonists
Electroconvulsive Therapy

